CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT

Welcome to the Brand page for “CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT”, which is offered here for Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for neurological use, attention deficit hyperactivity disorder, psychiatric diseases and disorders, all of which contain a compound that is a norepinephrine and dopamine-preferring triple reuptake inhibitor;.

Its status is currently believed to be active. Its class is unavailable. “CENTANAFADINE SR IS A NOREPINEPHRINE- AND DOPAMINE-PREFERRING TRIPLE REUPTAKE INHIBITOR THAT HAS THE RIGHT RATIO FOR THE RIGHT PATIENT” is believed to be currently owned by “NEUROVANCE, INC.”